|
|
|
||
Re: Is CELG partner (and 14% equity investment) trading at just 1x peak revenues eventhough at all time high of $57?I look for an easy double for both XLRN and Celgene but why do you think Celgene is so cheap now, can’t get any value to anything they do, they are very vulnerable in my view as those 5 drugs approval deadline approaches and stock trades at 5X 2020 EPS. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
220447 | Re: Is CELG partner (and 14% equity investment) trading at just 1x peak revenues eventhough at all time high of $57? | canesmonkey | 0 | 9/21/2018 8:53:49 AM |